Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Duke University Medical Center/Duke Cancer Institute

3 abstracts

Abstract
Molecular profiling of serial liquid biopsy specimens utilizing cell free DNA (cfDNA) and circulating tumor cells (CTCs) in TBCRC041: A phase II study of alisertib in endocrine resistant metastatic breast cancer (MBC).
Org: Mayo Clinic, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, University of Michigan, Duke University Medical Center/Duke Cancer Institute,
Abstract
Unveiling the cost-effectiveness of CDK4/6 inhibitors in treating patients with HR+/HER2- metastatic breast cancer: A closer look at nonmedication expenses.
Org: UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA, USA, Duke University Medical Center/Duke Cancer Institute,
Abstract
Spatial genomics to reveal an immunosuppressive tumor microenvironment after chemoradiation in head and neck cancer patients.
Org: Duke University Medical Center/Duke Cancer Institute, Genmab, Genmab Utrecht, Genmab US Inc., Janssen Research and Development LLC, Raritan, NJ,